Analysts: Emergent BioSolutions Inc (EBS.N)

EBS.N on New York Stock Exchange

17.89USD
1 Aug 2013
Price Change (% chg)

$0.20 (+1.13%)
Prev Close
$17.69
Open
$17.80
Day's High
$17.95
Day's Low
$17.38
Volume
47,464
Avg. Vol
50,780
52-wk High
$18.25
52-wk Low
$12.50

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 0.26 December 2 Aug 2013

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 3 3
(2) OUTPERFORM 3 3 2 2
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.60 1.60 1.40 1.40

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 5 81.14 86.18 76.22 85.50
Quarter Ending Dec-13 5 98.83 105.50 88.68 85.50
Year Ending Dec-13 5 298.80 305.10 293.95 317.14
Year Ending Dec-14 5 323.02 346.90 296.49 334.61
Earnings (per share)
Quarter Ending Sep-13 5 0.26 0.29 0.23 0.38
Quarter Ending Dec-13 5 0.49 0.62 0.33 0.38
Year Ending Dec-13 4 0.79 0.86 0.75 0.97
Year Ending Dec-14 5 0.95 1.12 0.72 1.20
LT Growth Rate (%) 1 10.00 10.00 10.00 32.00

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-13 46.17 43.10 3.07 6.65
Quarter Ending Dec-12 95.09 94.61 0.49 0.51
Quarter Ending Sep-12 68.49 66.59 1.90 2.77
Quarter Ending Jun-12 76.82 70.38 6.44 8.38
Quarter Ending Mar-12 47.32 50.31 2.99 6.32
Earnings (per share)
Quarter Ending Mar-13 -0.14 -0.22 0.08 -52.78
Quarter Ending Dec-12 0.45 0.44 0.01 1.68
Quarter Ending Sep-12 0.14 0.18 0.04 28.57
Quarter Ending Jun-12 0.23 0.21 0.02 8.70
Quarter Ending Mar-12 -0.15 -0.02 0.13 -86.30

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 81.14 81.14 81.14 81.14 85.50
Quarter Ending Dec-13 98.83 98.83 98.83 98.83 85.50
Year Ending Dec-13 298.80 298.80 298.80 298.80 317.14
Year Ending Dec-14 323.02 323.02 323.02 323.02 334.61
Earnings (per share)
Quarter Ending Sep-13 0.26 0.26 0.26 0.26 0.38
Quarter Ending Dec-13 0.49 0.49 0.49 0.49 0.38
Quarter Ending Dec-13 0.79 0.79 0.79 0.79 0.97
Quarter Ending Dec-14 0.95 0.95 0.95 0.95 1.20

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-13 0 0 0 0
Quarter Ending Dec-13 0 0 0 0
Year Ending Dec-13 0 0 0 0
Year Ending Dec-14 0 0 0 0
Earnings
Quarter Ending Sep-13 0 0 0 0
Quarter Ending Dec-13 0 0 0 0
Year Ending Dec-13 0 0 0 0
Year Ending Dec-14 0 0 0 0

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$15.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks